Roche Translational Cancer Research Fellowship

Dr Jim Smith and his multidisciplinary team of New Zealand experts in epigenomics have won the 2024 Roche Translational Cancer Research Fellowship (RTCRF).

The aim of their research project is to develop a targeted ctDNA-based DNA methylation panel for implementation alongside PSA, MRI, and other risk stratification data in a structured screening approach for men at risk of prostate cancer.

Dr Smith believes this innovative research programme will contribute to early prostate cancer detection, leading to improved survival, fewer unnecessary procedures, decreased cost of care, and a more equitable screening approach for NZ men.

Congratulations to Dr Smith and his team!